We are proud to announce the launch of SpringWorks Therapeutics. This mission-driven medicines company is dedicated to developing innovative potential new treatments for underserved patient communities. Originally conceived by Pfizer, SpringWorks presents a groundbreaking new model for collaboration across medical research and product development. Rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists, SpringWorks aims to advance transformative science for patients' benefit.
Through its collaborations, SpringWorks is focused on providing innovative treatments an additional avenue for development, with an initial effort aimed as advancing potential programs for four diseases, desmoid tumor, neurofibromatosis, hereditary xerocytosis and post-traumatic stress disorder, each of which currently has no cure.
The name SpringWorks Therapeutics is a reflection of the company’s approach to drug development: the company is springing into action to deliver treatments to people who are in great need and without alternatives.
Learn more about this innovative company from Pfizer’s Chief Medical Officer Dr. Freda Lewis-Hall.